中国医药公司营收100强：英科医疗、瑞康医药营收同比降超50亿元，恒瑞医药、中国中药、海王生物降超20亿元

市场资讯2022-08-31

2022上半年中国医药公司营收100强（搜索版）　　中国医药公司100强之涨幅榜（搜索版）　　中国医药公司市值100强排行榜（搜索版）　　近日，上市公司2022半年报出炉，新浪财经医药频道盘点A股H股上市的申万医药生物、申万美容护理公司情况。wind数据显示，从2022上半年营收看，国药控股营收2615亿元位居第一，上海医药营收1117亿元位居第二，华润医药营收1079亿元排名第三。点击查看...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

喵喵宠
2022-09-01
喵喵宠
生产的不如销售的，反映出产能过剩，生产企业急需新药来重新建立游戏规则，不排除企业和销售平台合作来快速回笼资金，提高效率。
- 小虎xh:
  好
- 花生糖:
  6
- 54d2b927:
  w

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2263846475?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2022-08-31 15:23","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2263846475","market":"hk","top_or_hot":-1,"title":"中国医药公司营收100强：英科医疗、瑞康医药营收同比降超50亿元，恒瑞医药、中国中药 、海王生物降超20亿元","media":"市场资讯","content":"<div>\n<p>2022上半年中国医药公司营收100强（搜索版）\n　　中国医药公司100强之涨幅榜（搜索版）\n　　中国医药公司市值100强排行榜（搜索版）\n　　近日，上市公司2022半年报出炉，新浪财经医药频道盘点A股H股上市的申万医药生物、申万美容护理公司情况。wind数据显示，从2022上半年营收看，国药控股营收2615亿元位居第一，上海医药营收1117亿元位居第二，华润医药营收1079亿元排名第三。点击查看...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/med/yyyc/2022-08-31/doc-imizmscv8510595.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>中国医药公司营收100强：英科医疗、瑞康医药营收同比降超50亿元，恒瑞医药、中国中药 、海王生物降超20亿元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n中国医药公司营收100强：英科医疗、瑞康医药营收同比降超50亿元，恒瑞医药、中国中药 、海王生物降超20亿元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-31 15:23 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/med/yyyc/2022-08-31/doc-imizmscv8510595.shtml><strong>市场资讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2022上半年中国医药公司营收100强（搜索版）\n　　中国医药公司100强之涨幅榜（搜索版）\n　　中国医药公司市值100强排行榜（搜索版）\n　　近日，上市公司2022半年报出炉，新浪财经医药频道盘点A股H股上市的申万医药生物、申万美容护理公司情况。wind数据显示，从2022上半年营收看，国药控股营收2615亿元位居第一，上海医药营收1117亿元位居第二，华润医药营收1079亿元排名第三。点击查看...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/med/yyyc/2022-08-31/doc-imizmscv8510595.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00570","symbol_name":"中国中药","start_time":0,"source_url":"https://finance.sina.com.cn/stock/med/yyyc/2022-08-31/doc-imizmscv8510595.shtml","article_id":"2263846475","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2263846475","pubTimestamp":1661930580,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"　　近日，上市公司2022半年报出炉，新浪财经医药频道盘点A股H股上市的申万医药生物、申万美容护理公司情况。wind数据显示，从2022上半年营收看，国药控股营收2615亿元位居第一，上海医药营收1117亿元位居第二，华润医药营收1079亿元排名第三。　　从营收同比减少的公司看，英科医疗、瑞康医药营收同比减少超过50亿元。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"300677":"英科医疗","600056":"中国医药","600276":"恒瑞医药","00570":"中国中药","002589":"瑞康医药","000078":"海王生物"},"translate_title":"Top 100 revenues of Chinese pharmaceutical companies: the revenues of Yingke Medical and Ruikang Medicine decreased by more than 5 billion yuan year-on-year, and Hengrui Medicine, Chinese Traditional Medicine and Haiwang Bio decreased by more than 2 billion yuan","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300677":1,"600056":1,"600276":1,"000078":1,"002589":1,"00570":1},"content_text":"2022上半年中国医药公司营收100强（搜索版）\n　　中国医药公司100强之涨幅榜（搜索版）\n　　中国医药公司市值100强排行榜（搜索版）\n　　近日，上市公司2022半年报出炉，新浪财经医药频道盘点A股H股上市的申万医药生物、申万美容护理公司情况。wind数据显示，从2022上半年营收看，国药控股营收2615亿元位居第一，上海医药营收1117亿元位居第二，华润医药营收1079亿元排名第三。点击查看。\n\n　　从上半年营收变化看，九安医疗营收暴增227亿元，排名从去年同期的310名提升至第九名，国药控股、华润医药营收同比增加123亿元。\n　　药明康德（维权）、京东健康、上海医药、九州通、安旭生物、智飞生物营收同比增加50亿元。\n　　迪安诊断、复星医药、明德生物、万泰生物、凯莱英、达安基因、国药一致、金域医学、药明生物、博腾股份（维权）、迈瑞医疗、重药控股、万孚生物、南京医药营收同比增加在20亿元--50亿元。\n\n　　从营收同比减少的公司看，英科医疗、瑞康医药营收同比减少超过50亿元。恒瑞医药、中国中药 、海王生物、 国药现代 、乐普医疗 、云南白药 、新华医疗营收同比减少超过10亿元。\n　　ST冠福（维权） 、百济神州 、中国医药、浙江医药 、上海家化、 辽宁成大、 以岭药业、 华北制药、 步长制药 、海正药业、 红日药业营收同比减少介于1--10亿元之间。\n\n\n炒股开户享福利，入金抽188元红包，100%中奖！\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：常福强","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":669045741,"gmtCreate":1662009878487,"gmtModify":1662009878487,"author":{"id":"3580286160303470","authorId":"3580286160303470","name":"喵喵宠","avatar":"https://static.tigerbbs.com/ed6c5b8f36aef3dfd447d8e4d7a7935e","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3580286160303470","authorIdStr":"3580286160303470"},"htmlText":"生产的不如销售的，反映出产能过剩，生产企业急需新药来重新建立游戏规则，不排除企业和销售平台合作来快速回笼资金，提高效率。","listText":"生产的不如销售的，反映出产能过剩，生产企业急需新药来重新建立游戏规则，不排除企业和销售平台合作来快速回笼资金，提高效率。","text":"生产的不如销售的，反映出产能过剩，生产企业急需新药来重新建立游戏规则，不排除企业和销售平台合作来快速回笼资金，提高效率。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/669045741","repostId":2263846475,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7631375,"gmtCreate":1662014010015,"gmtModify":1662014014032,"authorId":3546391892651929,"author":{"id":3546391892651929,"idStr":"3546391892651929","authorId":3546391892651929,"name":"小虎xh","avatar":"https://static.tigerbbs.com/004cefb5855766f136e58d0c94338c54","vip":1,"currentWearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.67%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":4,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":669045741,"type":1,"supId":0,"prevId":0,"content":" 好","text":" 好","html":" 好"},{"id":7631363,"gmtCreate":1662012946911,"gmtModify":1662012950464,"authorId":3576242079373430,"author":{"id":3576242079373430,"idStr":"3576242079373430","authorId":3576242079373430,"name":"花生糖","avatar":"https://static.tigerbbs.com/7692ee8030759378663610377d875179","vip":1,"crmLevel":6,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":669045741,"type":1,"supId":0,"prevId":0,"content":"6","text":"6","html":"6"},{"id":7631339,"gmtCreate":1662010968055,"gmtModify":1662010971693,"authorId":3567042130732000,"author":{"id":3567042130732000,"idStr":"3567042130732000","authorId":3567042130732000,"name":"54d2b927","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"currentWearingBadge":{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.14","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":669045741,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">w</span>","text":"<span class=\"s1\">w</span>","html":"<span class=\"s1\">w</span>"}],"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2263846475"}

中国医药公司营收100强：英科医疗、瑞康医药营收同比降超50亿元，恒瑞医药、中国中药 、海王生物降超20亿元

精彩评论

中国医药公司营收100强：英科医疗、瑞康医药营收同比降超50亿元，恒瑞医药、中国中药、海王生物降超20亿元